Delivery Order 75N95018D00010-75N95022F00001
Award Date 6/30/22
Potential Completion Date 3/31/25
Potential Value $107K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed price purchase order was awarded to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $7,951.40 award is for the delivery of custom antibody development services including monoclonal antibodies, cell lines, labeled antibodies, polyclonal antibodies, and peptide synthesis. These...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&G Pharmaceutical, Inc. (doing business as Precision Antibody), a for-profit manufacturer of goods. The $14,630.25 contract is for the development of monoclonal antibodies to support biomedical research. Precision Antibody has provided similar services to HHS components like the National Cancer Institute and Department of...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...
- The U.S. Department of Health and Human Services, National Institutes of Health, National Center for Advancing Translational Sciences awarded a firm-fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to generate drug-specific monoclonal antibodies against TTHX1114, an engineered mutant human FGF1. The $50,208.55 contract has a completion date of June 30, 2020 and does not have a set-aside designation. Precision Antibody is a for-profit...
- This $13,670 federal contract was awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc., doing business as Precision Antibody, a for-profit manufacturer of custom antibodies and related products for biomedical research. The contract was issued as a purchase order for the delivery of custom antibodies. Precision Antibody has a strong track record of federal contract awards, primarily from NIH institutes, for providing specialized biological materials and services to...
- This is a $5,820 firm-fixed price purchase order awarded by the National Institutes of Health (NIH) to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for monoclonal antibody production services. The contract is not set-aside and was awarded under the NIH's Acquisition Operations. Precision Antibody is a for-profit manufacturer of specialized biological materials and services, including custom antibody development, cell lines, and peptide synthesis, in support of biomedical...
- The federal contract award HHSN272201400119P was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the prime contractor A&G Pharmaceutical, Inc., doing business as Precision Antibody. The $30,264.00 firm-fixed-price purchase order is for the production of 1 mg of precision antibodies. This contract is not associated with a set-aside program. A&G Pharmaceutical, Inc. is a for-profit manufacturer of goods that...
- The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $5,286.50 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for custom antibody generation services. The award, with a completion date of December 18, 2013, is not associated with a set-aside designation. Precision Antibody is a for-profit manufacturer of goods specializing in custom antibody...
- The National Institute of Allergy and Infectious Diseases (NIAID), an agency within the U.S. Department of Health and Human Services, awarded a $18,500 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for laboratory testing, fusion, and cloning services. The contract has an ultimate completion date of November 30, 2024 and does not have a set-aside designation. This award is part of a larger $100 million Blanket Purchase Agreement (BPA)...
- This is a federal contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to A&G Pharmaceutical, Inc. (doing business as Precision Antibody). The $199,380 firm-fixed-price contract is for research and development related to biomedical products and was awarded on September 14, 2012, with a completion date of September 13, 2013. The contract does not have a set-aside designation. A&G Pharmaceutical, Inc. is a...